NCT00303017View on ClinicalTrials.gov

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

September 30, 2006

Conditions
Osteoarthritis
Interventions
DIETARY_SUPPLEMENT

flavocoxid

flavonoid mixture

DRUG

Naproxen

non-steroidal anti-inflammatory drug

Trial Locations (1)

32901

Timothy Truitt MD, Melbourne

Sponsors
All Listed Sponsors
lead

Primus Pharmaceuticals

INDUSTRY